Literature DB >> 3936349

Late deaths following radiotherapy for pediatric tumors.

D D Taylor, R A Potish.   

Abstract

From 1953 to 1975, 341 children received megavoltage radiation and survived at least 5 years. Chemotherapy was administered to 189 of these children. Although the expected age-adjusted 30-year survival was 97%, the observed survival was only 83%. Late recurrence of primary tumor was responsible for 24 of 37 deaths. Other causes of death included second neoplasm (4 patients), infection (4 patients), central nervous system complication (2 patients), inanition (1 patient), motor vehicle accident (1 patient), and miscellaneous (1 patient). Thus, 36 of the 37 late deaths were secondary to either the original cancer, a new cancer, or the effects of treatments. Brain tumors and Ewing's sarcoma have more late deaths while neuroblastomas have fewer late deaths than expected. Even after 25 years of follow-up, the survival of this cohort does not parallel that of the general population.

Entities:  

Mesh:

Year:  1985        PMID: 3936349     DOI: 10.1097/00000421-198512000-00005

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  4 in total

Review 1.  Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study.

Authors:  Gregory T Armstrong
Journal:  Eur J Paediatr Neurol       Date:  2010-01-27       Impact factor: 3.140

2.  Late deaths after treatment for childhood cancer.

Authors:  M M Hawkins; J E Kingston; L M Kinnier Wilson
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

3.  Long term survival and cure after childhood cancer.

Authors:  M M Hawkins
Journal:  Arch Dis Child       Date:  1989-06       Impact factor: 3.791

4.  Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.

Authors:  Gregory T Armstrong; Qi Liu; Yutaka Yasui; Sujuan Huang; Kirsten K Ness; Wendy Leisenring; Melissa M Hudson; Sarah S Donaldson; Allison A King; Marilyn Stovall; Kevin R Krull; Leslie L Robison; Roger J Packer
Journal:  J Natl Cancer Inst       Date:  2009-06-17       Impact factor: 11.816

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.